Oliveira et al.3535 Oliveira AR, Crua KJ, Morais JB, Severo JS, Freitas TE, Veras AL, et al. Magnesium status and its relationship with c-reactive protein in obese women. Biol Trace Elem Res. 2015; 168(2):296-302.
|
65 obese and 66 non-obese women Plasma, erythrocyte and urinary magnesium and C-reactive protein |
Obese women had plasma and erythrocyte magnesium concentrations similar to the control group Obese women had lower than normal values of magnesium in the urine Correlation between urinary concentrations of magnesium and C-reactive protein |
Farhangi et al.99 Farhangi MA, Ostadrahimi A, Mahboob S. Serum calcium, magnesium, phosphorous and lipid profile in healthy Iranian premenopausal women. Biochem Med. 2011; 21(3):312-20.
|
40 obese and 42 non-obese women Serum magnesium |
Obese women had lower serum magnesium concentrations than the control group |
Cruz et al.1010 Cruz KJC, Oliveira ARS, Pinto DP, Morais JBS, Lima FS, Colli C, et al. Influence of magnesium on insulin resistance in obese women. Biol Trace Elem Res. 2014; 160(3):305-10.
|
55 obese and 59 non-obese women Plasma, erythrocyte and urinary magnesium |
Obese women had plasma and erythrocyte magnesium concentrations similar to the control group Obese women presented values of urinary magnesium lower than normal |
Zemva e Zemva3636 Zemva A, Zemva Z. Ventricular ectopic activity, left ventricular mass, hyperinsulinemia, and intracellular magnesium in normotensive patients with obesity. Angiology. 2000; 51(2):101-6.
|
32 obese and 32 non-obese individuals Plasma and erythrocyte magnesium |
Obese individuals had lower plasma and erythrocyte magnesium values compared to the control group |
Corica et al.3737 Corica F, Allegra A, Ientile R, Buemi M. Magnesium concentrations in plasma, erythrocytes, and platelets in hypertensive and normotensive obese patients. Am J Hypertens. 1997; 10(11):1311-3.
|
19 obese normotensive, 19 obese hypertensive, and 15 non-obese individuals Plasma, erythrocyte and platelet magnesium |
Lower plasma, erythrocyte and platelet magnesium levels in the normotensive and hypertensive obese group compared to the control group |
Bertinato et al.3838 Bertinato J, Wu Xiao C, Ratnayake WM, Fernandez L, Lavergne C, Wood C, et al. Lower serum magnesium concentration is associated with diabetes, insulin resistance, and obesity in South Asian and white Canadian women but not men. Food Nutr Res. 2015; 59:25974.
|
276 southern Asian and 315 Caucasian individuals. Serum magnesium |
Obese women had lower serum magnesium values than normal and overweight women |
Suliburska et al.3939 Suliburska J, Cofta S, Gajewska E, Kalmus G, Sobieska M, Samborski W, et al. The evaluation of selected serum mineral concentrations and their association with insulin resistance in obese adolescents. Eur Rev Med Pharmacol Sci. 2013; 17(17):2396-400.
|
78 obese and 20 non-obese adolescents Serum magnesium |
Obese adolescents presented lower serum magnesium compared to the control group |
Song et al.4141 Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005; 28(6):1438-44.
|
11,686 women aged ≥ 45 years Magnesium content in diet and plasma C-reactive protein |
Inverse association between plasma C-reactive protein concentrations and dietary magnesium content after adjustment for age and body mass index |
Guerrero-Romero et al.4343 Guerrero-Romero F, Bermudez-Peña C, Rodríguez-Morán M. Severe hypomagnesemia and low-grade inflammation in metabolic syndrome. Magnes Res. 2011; 24(2):45-53.
|
51 women and 47 men Serum magnesium, TNF-α and C-reactive protein |
Severe hypomagnesemia in individuals with metabolic syndrome, a parameter strongly related to the serum concentrations of C-reactive protein and TNF-α |
Moslehi et al.5757 Moslehi N, Vafa M, Rahimi-Foroushani A, Golestan B. Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women. J Res Med Sci. 2012; 17(7):607-14.
|
69 overweight women Serum magnesium and C-reactive protein, and plasma IL-6 Supplementation with 250 mg/day of magnesium oxide for 8 weeks |
Magnesium serum concentrations were inversely correlated with C-reactive protein before supplementation However, supplementation with magnesium did not alter the serum concentrations of this mineral, and did not reduce the levels of C-reactive protein and IL-6 |
Rodriguez-Hernandez et al.5858 Rodriguez-Hernandez H, Cervantes-Huerta M, Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation decreases alanine aminotransferase levels in obese women. Magnes Res. 2010; 23(2):90-6.
|
38 obese women Serum magnesium and C-reactive protein Supplementation with 450 mg/day of magnesium chloride for 4 weeks |
No reduction in C-reactive protein concentrations was observed in obese women treated with supplements |
Simental-Mendía et al.5959 Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial. Arch Med Res. 2014; 45(4):325-30.
|
62 men and women diagnosed as pre-diabetic Serum magnesium and C-reactive protein Supplementation with 382 mg/day of magnesium chloride for 12 weeks |
Oral magnesium supplementation reduced levels of C-reactive protein in subjects with pre-diabetes and hypomagnesemia |
Niranjan et al.6060 Niranjan G, Anitha D, Srinivasan AR, Velu VK, Venkatesh C, Babu MS, et al. Association of inflammatory sialoproteins, lipid peroxides and serum magnesium levels with cardiometabolic risk factors in obese children of South Indian population. Int J Biomed Sci. 2014; 10(2):118-23.
|
62 obese children and 60 controls Serum magnesium and C-reactive protein |
Reduced serum magnesium concentrations were seen in the case group compared to the control, as well as of C-reactive protein |